Share price: 112.80p

ADDITIONAL LISTING / TVR

28th March 2008

The Company announces that on 28 March 2008 it resolved to issue 67,725 new ordinary shares of 10p each to certain employees of the group to certain employees of the Company. These shares are to be issued pursuant to the terms of the deferred consideration contained within the share purchase agreement with S.M.T. Consulting Limited, a wholly owned subsidiary of the Company.

Application has been made for these shares to be admitted to trading on AIM and admission is expected to occur on 3 April 2008.

The Company’s issued share capital, will following admission of the 67,725 deferred consideration shares, consist of 38,911,577

ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 80,000 Ordinary Shares in treasury

at the date of this announcement. The total number of current voting rights in the Company will therefore be 38,831,577.

The above figure (38,831,577 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they

will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA’s Disclosure and Transparency Rules.

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150